The pharmaceutical contract manufacturing sector is witnessing significant growth due to the increasing prevalence of chronic and infectious diseases. The demand for biologics and biopharmaceuticals is driving this expansion, leading to a lucrative market opportunity. The industry is experiencing strong growth with key players tapping into the market potential.